Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
| ▸ | PIM1 | P11309 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 2/20 | 0.36 |
| ▸ | HTR7 | P34969 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12258277 | 0.87 | DHFR (0.49) | MCL1SIGMAR1DHFRHTTNPSR1 | |
| SCHEMBL13367483 | 0.83 | SIGMAR1 (0.41) | SIGMAR1DHFRHTR1AHTR7KDM4E | |
| SCHEMBL13367492 | 0.81 | SIGMAR1 (0.40) | SIGMAR1DHFRHTR1AHTR7KDM4E | |
| SCHEMBL27380432 | 0.81 | SLC6A9 (0.42) | MCL1SIGMAR1DHFRL3MBTL1KDM4E | |
| SCHEMBL13826295 | 0.81 | PSMB5 (0.41) | SIGMAR1HTTNPSR1L3MBTL1KDM4E | |
| SCHEMBL13338461 | 0.81 | KDM4E (0.39) | SIGMAR1PIM1HTTNPSR1L3MBTL1 | |
| SCHEMBL13432405 | 0.79 | PDK2 (0.40) | MCL1SIGMAR1DHFRHTR1AHTR7 | |
| SCHEMBL13367489 | 0.79 | SIGMAR1 (0.45) | SIGMAR1DHFRHTR1AHTR7 | |
| SCHEMBL19735310 | 0.79 | ALDH1A1 (0.39) | MCL1SIGMAR1KDM4E | |
| SCHEMBL20516077 | 0.79 | MCL1 (0.53) | MCL1SIGMAR1DHFRHTTNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | MCL1 2865/4885SIGMAR1 699/4885DHFR 2406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.